Are we already becoming a cashless economy? This is just one of the key questions arising amidst the challenges of the coronavirus pandemic. Things have been forced to change, with Finance and Technology (Fintech) being the key driver.
New sectors such as digital payments, neobanks, and cash alternatives have not only thrived during the fallout, but allowed many to survive. Are we just seeing the tip of the iceberg for innovation? Or will things just go back to the way they were?
This report covers a number of fast moving fintech stocks that we believe are doing just that, including Afterpay Touch (ASX: APT), Novatti Group (ASX: NOV), Flexigroup (ASX: FXL), and Wisr (ASX: WZR).
This is only a brief excerpt of the Cashless Economy report. To download it in full, simply register for free below.
*Owners of this website are NOV shareholders
**NOV has engaged Principal IR on retainer to assist with Investor Communications
Alfred Chan is a Director of Principal Investor Relations (Principal) (ABN: 51 633 750 928) and an Authorised Representative of Emerald Financial Group ABN 85 106 823 741 which holds Australian Financial Services License number 241041.
Any advice contained in this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
“Investing is about understanding your risk” and every time you invest in the share market there is a risk of loss. If you are thinking about acquiring a financial product, you should consult our Financial Services Guide (FSG) at www.emeraldfinancial.com.au and the relevant Product Disclosure Statement first.
Please note past performance is not a reliable indicator of future performance.
All Figures in this report were correct as of 29th May 2020.
- Gage Roads opens first taproom, microbrewery and hospitality venue - September 24, 2020
- CardieX partners with tech giant Mobvoi for new health smartwatch - September 24, 2020
- Telix submits FDA application for new prostate cancer imaging product - September 24, 2020